Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
malaymail16h
Hold my Ozempic: British Vogue editor sounds alarm over comeback of ultra-thin models
LONDON, Nov 14 — The editorial director of British Vogue magazine on Wednesday said she was worried about the return of thin ...
Roxy Jacenko reveals why she stacked on 18kg in a year when she moved to Singapore - and what happened the day she overdosed on Ozempic
Roxy Jacenko has revealed how she gained 18kg after moving to Singapore in 2023 with her husband Oliver Curtis and their two ...
MedPage Today3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
What to know about the risks of using weight loss drugs unsupervised
The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...
health.economictimes.indiatimes5d
Weight Loss drugs may alter treatment paradigm for chronic disorders, say experts
Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...
verywellhealth6d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...
Medscape7d
Do Patients on Anti-Obesity Drugs Decrease Alcohol Use?
SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...
Novo Nordisk expects high demand for obesity drugs in India: Country head
The company is still 'evaluating' the price of the drug, but is confident that the price-sensitive Indian population will be able to afford it, Novo's India Managing Director Vikrant Shrotriya said ...